These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2521065)

  • 21. An open clinical trial of fluoxetine in the treatment of obsessive-compulsive disorder.
    Fontaine R; Chouinard G
    J Clin Psychopharmacol; 1986 Apr; 6(2):98-101. PubMed ID: 3517083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mania in a panic disorder patient treated with fluoxetine.
    Sholomskas AJ
    Am J Psychiatry; 1990 Aug; 147(8):1090-1. PubMed ID: 2375448
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug response assessed by the Modified Maudsley Obsessive-Compulsive Inventory.
    Dominguez RA; Jacobson AF; de la Gandara J; Goldstein BJ; Steinbook RM
    Psychopharmacol Bull; 1989; 25(2):215-8. PubMed ID: 2602515
    [No Abstract]   [Full Text] [Related]  

  • 24. Cognitive behavior therapy for treatment-refractory panic disorder.
    Pollack MH; Otto MW; Kaspi SP; Hammerness PG; Rosenbaum JF
    J Clin Psychiatry; 1994 May; 55(5):200-5. PubMed ID: 8071270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy assessment of fluoxetine treatment of outpatients with obsessive-compulsive disorder: a preliminary report].
    Wandzel L
    Psychiatr Pol; 1997; 31(4):429-35. PubMed ID: 9527686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiobsessive effect of fluoxetine.
    Fontaine R; Chouinard G
    Am J Psychiatry; 1985 Aug; 142(8):989. PubMed ID: 3875293
    [No Abstract]   [Full Text] [Related]  

  • 27. Serotonin selectivity for obsessive compulsive and panic disorders.
    Montgomery SA; Bullock T; Fineberg N
    J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):30-5. PubMed ID: 1931935
    [No Abstract]   [Full Text] [Related]  

  • 28. Meta-analysis of aggression and/or hostility-related events in children and adolescents treated with fluoxetine compared with placebo.
    Tauscher-Wisniewski S; Nilsson M; Caldwell C; Plewes J; Allen AJ
    J Child Adolesc Psychopharmacol; 2007 Oct; 17(5):713-8. PubMed ID: 17979590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluoxetine versus trazodone: efficacy and activating-sedating effects.
    Beasley CM; Dornseif BE; Pultz JA; Bosomworth JC; Sayler ME
    J Clin Psychiatry; 1991 Jul; 52(7):294-9. PubMed ID: 2071559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug treatment of obsessive-compulsive disorders--a comparative study of the effectiveness of clomipramine and fluoxetine].
    Volk S
    Fortschr Neurol Psychiatr; 1995 Jun; 63 Suppl 1():28-32. PubMed ID: 7635392
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy of trazodone as an anti obsessional agent.
    Prasad A
    Pharmacol Biochem Behav; 1985 Feb; 22(2):347-8. PubMed ID: 3983224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term fluoxetine treatment of a large number of obsessive-compulsive patients.
    Levine R; Hoffman JS; Knepple ED; Kenin M
    J Clin Psychopharmacol; 1989 Aug; 9(4):281-3. PubMed ID: 2504781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients.
    Pols H; Verburg K; Hauzer R; Meijer J; Griez E
    Biol Psychiatry; 1996 Nov; 40(9):913-7. PubMed ID: 8896779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive style, alprazolam plasma levels, and treatment response in panic disorder.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    Depress Anxiety; 2008; 25(8):E18-26. PubMed ID: 17960759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obsessive-compulsive and panic symptoms in patients with first-admission psychosis.
    Craig T; Hwang MY; Bromet EJ
    Am J Psychiatry; 2002 Apr; 159(4):592-8. PubMed ID: 11925297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder.
    Pollack MH; Otto MW; Tesar GE; Cohen LS; Meltzer-Brody S; Rosenbaum JF
    J Clin Psychopharmacol; 1993 Aug; 13(4):257-63. PubMed ID: 8376613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluoxetine-induced akathisia in male OCD patients.
    Friedman EH
    J Clin Psychiatry; 1990 May; 51(5):212. PubMed ID: 2378629
    [No Abstract]   [Full Text] [Related]  

  • 38. Alexithymia in DSM-IV disorder: comparative evaluation of somatoform disorder, panic disorder, obsessive-compulsive disorder, and depression.
    Bankier B; Aigner M; Bach M
    Psychosomatics; 2001; 42(3):235-40. PubMed ID: 11351112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder.
    Riddle MA; Scahill L; King RA; Hardin MT; Anderson GM; Ort SI; Smith JC; Leckman JF; Cohen DJ
    J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1062-9. PubMed ID: 1429406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Personality disorders and obsessive-compulsive disorder: critical analysis of the literature data and our studies].
    Bellino S; Barzega G; Bogetto F; Maina G; Ravizza L
    Minerva Psichiatr; 1995 Mar; 36(1):47-50. PubMed ID: 7643732
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.